Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M50.9Revenue $M17.1Net Margin (%)-45.1Z-Score-14.0
Enterprise Value $M72.0EPS $-0.2Operating Margin %-43.5F-Score4
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-45.0Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio1.9Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %-17.4Current Ratio3.4Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-71.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M47.5ROI % (ttm)-116.8Gross Margin Increase y-yN

Gurus Latest Trades with VSCI

Number of guru portfolios checked: 56.

No Entry found!

VSCI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


VSCI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PELL LEWIS CDirector, 10% Owner 2014-06-06Buy10,000$1.13-7.96 view
PELL LEWIS CDirector, 10% Owner 2014-05-21Buy5,000$1.09-4.59 view
PELL LEWIS CDirector, 10% Owner 2014-05-16Buy14,197$1.021.96 view
PELL LEWIS CDirector, 10% Owner 2013-11-18Buy6,296$0.9114.29 view
PELL LEWIS CDirector, 10% Owner 2013-11-15Buy20,000$0.915.56 view
PELL LEWIS CDirector, 10% Owner 2013-09-18Buy16,000$0.9114.29 view
PELL LEWIS CDirector, 10% Owner 2013-09-13Buy5,000$0.9213.04 view
PELL LEWIS CDirector, 10% Owner 2013-09-10Buy5,000$0.9213.04 view
PELL LEWIS CDirector, 10% Owner 2013-09-09Buy4,564$0.959.47 view
PELL LEWIS CDirector, 10% Owner 2013-09-06Buy5,000$0.977.22 view

Press Releases about VSCI :

    Quarterly/Annual Reports about VSCI:

    News about VSCI:

    Articles On GuruFocus.com
    The Barclays Triggers More Insider Buying Mar 13 2013 
    VisionSciences Inc. Reports Operating Results (10-Q) Feb 09 2011 
    VisionSciences Inc. Reports Operating Results (10-Q) Nov 10 2010 
    VisionSciences Inc. Reports Operating Results (10-Q) Aug 11 2010 
    VisionSciences Inc. Reports Operating Results (10-Q) Feb 11 2010 
    VisionSciences Inc. Reports Operating Results (10-Q) Nov 12 2009 
    VisionSciences Inc. Reports Operating Results (10-Q) Feb 13 2009 

    More From Other Websites
    VISION SCIENCES INC /DE/ Files SEC form 8-K, Other Events Jul 08 2014
    VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers Jun 27 2014
    VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Jun 17 2014
    VISION SCIENCES INC /DE/ Financials Jun 06 2014
    VISION SCIENCES INC /DE/ Files SEC form 10-K, Annual Report May 30 2014
    Vision-Sciences Introduces Next Generation, EndoSheath(R) Bronchoscopy System May 19 2014
    Vision-Sciences' CEO Discusses F4Q 2014 Results - Earnings Call Transcript Apr 29 2014
    VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 28 2014
    Vision-Sciences Announces Record Revenues of $5.0 Million for Fourth Quarter and $17.1 Million for... Apr 28 2014
    Vision-Sciences to Discuss EndoSheath(R) Technology on "Taking Stock with Pimm Fox" Mar 17 2014
    Vision-Sciences to Present at BTIG's Inaugural Snowbird Medical Technology and Diagnostics... Mar 13 2014
    Patient Safety Awareness Week Brings Awareness to Health Care-Acquired Infection Mar 04 2014
    VISION SCIENCES INC /DE/ Files SEC form 10-Q, Quarterly Report Feb 14 2014
    Vision-Sciences' CEO Discusses F3Q 2014 Results - Earnings Call Transcript Feb 04 2014
    Vision-Sciences Announces Revenue of $4.5 Million for Third Quarter and $12.1 Million for First Nine... Feb 03 2014
    VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 03 2014
    Vision-Sciences to Host Third Quarter Fiscal 2014 Results Call Jan 24 2014
    Vision-Sciences' EndoSheath(R) Technology Offers Patented Solution to "Nightmare Bacteria" Jan 13 2014
    Vision-Sciences Selected as Preferred Vendor for Endoscopy Equipment by 21st Century Oncology Dec 19 2013
    VISION SCIENCES INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Dec 17 2013

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide